158 related articles for article (PubMed ID: 9352742)
1. Prognostic factors in elderly patients with non-Hodgkin's lymphoma treated with cyclophosphamide, vincristine, prednisone, bleomycin, Adriamycin, procarbazine (COP-BLAM) therapy.
Niitsu N
Acta Haematol; 1997; 98(3):130-5. PubMed ID: 9352742
[TBL] [Abstract][Full Text] [Related]
2. Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Eur J Haematol; 1996 Mar; 56(3):163-7. PubMed ID: 8598236
[TBL] [Abstract][Full Text] [Related]
3. The cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin, and procarbazine (COPBLAM-I) regimen for intermediate-grade non-Hodgkin's lymphoma. Long term follow-up in 51 patients.
Shpilberg O; Shiff J; Chetrit A; Ramot B; Ben-Bassat I
Cancer; 1994 Dec; 74(11):3029-33. PubMed ID: 7525042
[TBL] [Abstract][Full Text] [Related]
4. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
Arai N; Hara A; Kaneko H; Umeda M; Shirai T
Nihon Ronen Igakkai Zasshi; 1991 Sep; 28(5):672-7. PubMed ID: 1721658
[TBL] [Abstract][Full Text] [Related]
5. The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.
Coleman M; Armitage JO; Gaynor M; McDermott D; Weisenburger DD; Adler K; Beshevkin M; Silver RT; Reisman AM; Pasmantier MW
Semin Hematol; 1988 Apr; 25(2 Suppl 2):23-33. PubMed ID: 2456620
[TBL] [Abstract][Full Text] [Related]
6. [The COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
Arai N; Hara A; Kaneko H; Shirai T
Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):357-62. PubMed ID: 1699013
[TBL] [Abstract][Full Text] [Related]
7. Advances in chemotherapy for large cell lymphoma.
Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
[TBL] [Abstract][Full Text] [Related]
8. [COP-BLAM III regimen for elderly non-Hodgkin's lymphoma].
Niitsu N; Umeda M; Shirai T
Nihon Ronen Igakkai Zasshi; 1993 Sep; 30(9):753-8. PubMed ID: 7693992
[TBL] [Abstract][Full Text] [Related]
9. European experience with ifosfamide in lymphomas.
von Kalle AK; Schaadt M; Diehl V
Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
[TBL] [Abstract][Full Text] [Related]
10. COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Eur J Haematol; 1995 Aug; 55(2):88-92. PubMed ID: 7543059
[TBL] [Abstract][Full Text] [Related]
11. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.
Vose JM; Armitage JO; Weisenburger DD; Bierman PJ; Sorensen S; Hutchins M; Moravec DF; Howe D; Dowling MD; Mailliard J
J Clin Oncol; 1988 Dec; 6(12):1838-44. PubMed ID: 2462026
[TBL] [Abstract][Full Text] [Related]
12. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma.
Niitsu N; Umeda M
Int J Hematol; 1994 Jul; 60(1):71-8. PubMed ID: 7522616
[TBL] [Abstract][Full Text] [Related]
14. Response and adverse drug reactions to combination chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma: comparison of CHOP, COP-BLAM, COP-BLAM III, and THP-COPBLM.
Niitsu N; Umeda M
Eur J Haematol; 1999 Nov; 63(5):337-44. PubMed ID: 10580566
[TBL] [Abstract][Full Text] [Related]
15. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
[TBL] [Abstract][Full Text] [Related]
16. [The COP-BLAM III therapy of non-Hodgkin's lymphoma].
Arai N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1991 Nov; 32(11):1447-52. PubMed ID: 1721937
[TBL] [Abstract][Full Text] [Related]
17. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of COP-BLAM therapy with concomitant G-CSF in elderly patients with non-Hodgkin's lymphoma in comparison with patients not given G-CSF].
Niitsu N; Umeda M
Nihon Ronen Igakkai Zasshi; 1995 Jun; 32(6):410-5. PubMed ID: 7563935
[TBL] [Abstract][Full Text] [Related]
19. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Niitsu N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1993 Jul; 34(7):829-34. PubMed ID: 7689661
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
Niitsu N; Umeda M
Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]